Skip to main content
Lite Strategy, Inc. logo

Lite Strategy, Inc. — Investor Relations & Filings

Ticker · LITS ISIN · US55279B2025 US Financial and insurance activities
Filings indexed 991 across all filing types
Latest filing 2023-11-15 Director's Dealing
Country US United States of America
Listing US LITS

About Lite Strategy, Inc.

https://litestrategy.com/

Lite Strategy, Inc. is a publicly traded company that has adopted Litecoin (LTC) as its primary treasury reserve asset. The company's core strategy involves accumulating and holding pure LTC through active treasury management, with the stated objective of increasing LTC exposure per share for its shareholders. This model provides public market investors with a vehicle for institutional exposure to the digital asset. Formerly known as MEI Pharma, Inc., a clinical-stage oncology company, the corporation rebranded and pivoted its business model in 2025 to focus on its Litecoin treasury operations.

Recent filings

Filing Released Lang Actions
Director's Dealing 2023
Director's Dealing
2023-11-15 English
8-K
Regulatory Filings
2023-11-09 English
10-Q
Interim / Quarterly Report Q1 2024
2023-11-09 English
ARS
Annual Report
2023-11-08 English
DEFA14A
Regulatory Filings
2023-11-08 English
DEF 14A
Proxy Solicitation & Information Statement
2023-11-08 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.